Recombinant GPNMB (Glembatumumab Biosimilar) antibody
Quick Overview for Recombinant GPNMB (Glembatumumab Biosimilar) antibody (ABIN7581430)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Expression System
 - CHO Cells
 - 
                                            
Purpose
 - Anti-GPNMB Reference Antibody (glembatumumab)
 - 
                                            
Sequence
 - QVQLQESGPG LVKPSQTLSL TCTVSGGSIS SFNYYWSWIR HHPGKGLEWI GYIYYSGSTY SNPSLKSRVT ISVDTSKNQF SLTLSSVTAA DTAVYYCARG YNWNYFDYWG QGTLVTVSSA STKGPSVFPL APCSRSTSES TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSNFGTQTY TCNVDHKPSN TKVDKTVERK CCVECPPCPA PPVAGPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTFRV VSVLTVVHQD WLNGKEYKCK VSNKGLPAPI EKTISKTKGQ PREPQVYTLP PSREEMTKNQ VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPMLDSDG SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK,EIVMTQSPAT LSVSPGERAT LSCRASQSVD NNLVWYQQKP GQAPRLLIYG ASTRATGIPA RFSGSGSGTE FTLTISSLQS EDFAVYYCQQ YNNWPPWTFG QGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
 - 
                                            
Characteristics
 - Anti-GPNMB Reference Antibody (glembatumumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
 - 
                                            
Purity
 - >95 %
 - 
                                            
Isotype
 - IgG2SA
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Comment
 - 
                        
Therapeutic Agents by Target and Mechanism: GPNMB regulators
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Concentration
 - 1 mg/mL
 - 
                                            
Buffer
 - 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
 - 
                                            
Storage
 - 4 °C,-80 °C
 - 
                                            
Storage Comment
 - +4°C,-80°C
 
 - 
                                            
 - 
    
- GPNMB (Glembatumumab Biosimilar)
 - 
                                            
Target Type
 - Biosimilar
 - 
                                            
Molecular Weight
 - 145.5 kDa
 - 
                                            
UniProt
 - Q14956
 
Target
 -